NorwoodLabs
Guide · Legal

Is RU-58841 Legal in the UK?

The legal position on RU-58841 and pyrilutamide in the UK, explained without the usual hedging: what they are under the law, where the line sits, and what 'for research use only' actually protects.

27 August 2026·7 min read·Research use only
The short version
  • RU-58841 is not a controlled substance in the UK. It is not scheduled under the Misuse of Drugs Act 1971.
  • It is not a licensed medicine. The MHRA has never authorised it, and it cannot be sold or marketed as a treatment.
  • The legal position turns on the research-use framing. Sold as a reference material for laboratory research, it sits in one category. Sold for human use, it moves into UK medicines law.
  • Norwood Labs sells both RU-58841 and pyrilutamide strictly as reference materials for research. Nothing here is legal advice.

The short answer

In the UK, RU-58841 is legal to buy and hold as a research chemical, but it is not a medicine. The two facts come from different pieces of law, and most of the confusion around this compound comes from people collapsing them into one question. Is it a banned drug? No. Is it an approved treatment? Also no. Those two statements are both true, and they are the whole of the answer.

What the Misuse of Drugs Act says

The Misuse of Drugs Act 1971 (and the Misuse of Drugs Regulations 2001 made under it) lists the substances the UK treats as controlled drugs: the opiates, stimulants, cannabis and the rest.RU-58841 is not on that list. Nor is pyrilutamide. Neither is a Class A, B or C drug, and neither appears in the Schedules, so possession, purchase and supply are not criminal offences under that Act. This is the cleanest part of the legal picture, and the one most people actually mean when they ask.

The Psychoactive Substances Act 2016, which catches substances with psychoactive effects that fall outside the Misuse of Drugs Act, also does not apply here. RU-58841 and pyrilutamide are androgen receptor antagonists. They are not psychoactive, and nothing in their pharmacology would bring them into that Act’s scope.

Where the line actually is: medicines law

The real legal boundary is not criminal drug law. It is medicines regulation, and it runs through the Human Medicines Regulations 2012 and the Medicines Act 1968. A substance becomes a “medicinal product” when it is presented as treating or preventing disease, or when its function is to restore or modify a physiological function in humans. What matters is less the molecule and more how it is sold and described.

That is why the research-use framing is not cosmetic. A supplier selling RU-58841 as a reference standard for laboratory work is operating outside medicines law. A supplier selling it for hair loss, with application instructions is presenting it as a medicine, and that is where the exposure begins: supplying an unlicensed medicinal product, and advertising one, are both regulated activities with serious consequences. The molecule did not change between the two scenarios. The presentation did.

What that means in practice

For a UK buyer, the honest summary is this: purchasing and possessing RU-58841 or pyrilutamide as a research chemical is not a criminal offence, because neither compound is a controlled substance. The risk sits on the supply and marketing side, not the purchase side, and it is concentrated entirely in the human-use framing. That is the precise reason every reputable supplier repeats “for research use only” on every page, ships with a certificate of analysis rather than a leaflet, and declines to give dosing or application guidance. It is not coyness. It is the thing that keeps the entire category lawful.

Pyrilutamide: same position, one difference

Pyrilutamide (KX-826) sits in the same legal category as RU-58841: not controlled, not licensed as a medicine in the UK. The one difference is context. Pyrilutamide is a modern drug candidate with company-reported Phase 3 data, so it is closer to the medicines line in appearance even though it holds no UK authorisation. That makes the research-use framing even more important for it, not less. The same rule applies to both: sold as a reference material for research, lawful. Presented as a treatment, not.

The caveat

None of this is legal advice, and the law is not static. Medicines regulation and novel psychoactive-substance law are both areas that shift. If you are buying or supplying research chemicals and the position matters to you, get professional legal advice rather than trusting a product page, this one included. What this page can tell you honestly is how the compounds are currently classified, and how Norwood Labs sells them: as reference materials for laboratory research, with a per-batch Certificate of Analysis, and with no treatment claims of any kind.

Related reading

For the science rather than the law, start with What Is RU58841? and the comparison in RU-58841 vs Pyrilutamide.

Reference · FAQ

Frequently asked.

Is RU-58841 a controlled substance in the UK?

No. RU-58841 is not listed under the Misuse of Drugs Act 1971 or the Misuse of Drugs Regulations 2001, and it is not a psychoactive substance covered by the Psychoactive Substances Act 2016. It sits outside the controlled-drug framework entirely.

Is pyrilutamide legal in the UK?

Pyrilutamide (KX-826) is in the same position as RU-58841: it is not a controlled substance under the Misuse of Drugs Act, and it is not licensed by the MHRA as a medicine in the UK. It can be sold as a reference material for research, but not as a medicine for human use.

Can I buy RU-58841 in the UK for research?

Suppliers such as Norwood Labs offer RU-58841 and pyrilutamide as reference materials for laboratory research use only, and that is the framing under which they are legally offered. Buying for genuine research purposes sits inside that framing. Supplying or marketing them for human consumption would be a different legal position under UK medicines law.

Is RU-58841 a medicine?

No. Neither RU-58841 nor pyrilutamide holds a UK marketing authorisation from the MHRA. RU-58841 never completed human clinical trials, and pyrilutamide has only company-reported trial data from China. Neither can legally be sold or advertised as a treatment for any condition.